Product

Company

NCT03127787·4 sites·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Beckman Coulter, Inc.

same as brief summary

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

≥ 18 years old
Must have had a kidney transplant and be evaluated for post-transplantation care
Must have demonstrated post-transplant CMV DNAemia
Must be eligible for and treated with anti-CMV drugs

The record

StatusTerminated

PhaseNo phase

Taking part19

StartedJun 2016

UpdatedJul 12, 2018

Conditions

Where4

Clareo Health | Clinical Performance Evaluation of DxN CMV Assay